Schedule 13G ownership disclosure

IMMUNOGEN INC

Security class unavailable · CUSIP: 45253H101

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,902,498
Percent of class
6.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-22-000001
Form type
SC 13G/A
Filer
ImmunoGen, Inc.
CIK
CIK 855654
Filed
Jan 10, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub